Latest Blogs

Guest Commentary
Nov 28, 2023
Women Mentoring Women: A Thank You Note to My Two Heroes
Dr. Tara Rajendran honors two women who, through their kindness and thoughtful attention, shaped her professional path from an early age.
Linda R. Duska, MD, MPH
Nov 20, 2023
The Potential of AI in Clinical Research
"We all need to stay informed and engaged on the topic of AI in order to be the best advocates for ourselves, our profession, and our patients."
International Perspectives
Nov 03, 2023
Cancer, Conflict, and Catastrophe: A Cry for Help From Sudan, a Country at War
Millions of people have been affected by the war in Sudan, and the outlook for patients with cancer is particularly dire. Dr. Nabeeha Karadawi, Dr. Salma Awad Elkareem Ali Mohamed, and Nagham Ali outline the current situation and call for immediate international aid.
Abdul-Rahman Jazieh, MD, MPH
Oct 24, 2023
Should Oncologists Continue to Be Ambivalent About Dietary Supplement Use by Their Patients?
If we believe that dietary supplements are active compounds—and many are—then we should deal with them as medications and advise our patients accordingly.
Subscribe to this column

Clifford A. Hudis, MD, FASCO, FACP

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Disclosure.

Jan 14, 2019
A Conversation With Dr. Beverly Moy: Removing Financial Barriers to Clinical Trials Participation
Social injustice is perpetuated when patients can't afford to participate in essential clinical research.
Oct 03, 2018
Medicaid Work Requirements: A Conversation With Dr. Manali Patel
The chair-elect of the ASCO Health Equity Committee and I discuss concerns with proposed Medicaid work requirements and their impact on patients with cancer and their physicians.
Sep 11, 2018
Concerns With 2019 Medicare Physician Fee Schedule and Quality Payment Program Proposed Rule
We remain very concerned that the CMS proposal could harm Medicare beneficiaries who have cancer by triggering major cuts to physician reimbursement, especially for Part B drugs and for drugs that have been newly introduced to the market.
1 Comments
Aug 28, 2018
Highlights of August Board of Directors Meeting: Membership Value and Personalization
At the latest ASCO Board of Directors Meeting, we discussed countering biases, improving rural access to quality cancer care, and effectively adding more value to your ASCO membership. 
Aug 24, 2018
Share Your Story: Why Do You Live to Conquer Cancer?
ASCO's "I Live to Conquer Cancer" campaign is putting a human face on the results of cancer research and the researchers who make this progress.
Aug 07, 2018
Caring for, Learning From Every Patient: A Conversation With Dr. Monica M. Bertagnolli
I spoke with our current ASCO president about her theme for the year, her work with the Alliance for Clinical Trials in Oncology, and her frontier spirit.

Pages